While STING agonists were recently suggested to synergize with CAR T cells and enhance their ability to control tumor growth,58 our findings provide impetus for studying the relevance of STING activation in TH9 cells in the context of adoptive T-cell therapy for cancer. Here, STING1 is linked to neoplasm.